Patent Opposition Database

Hide annotations

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 201717032083
Who filed: Delhi Network of Positive People
Country: India
Opposition type: Pre-Grant
Opposition status: Application withdrawn by applicant.
Date: 17-11-2021
Patent type: Molecules

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

10 similar patent oppositions

Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)

Countries: India Date: 2021
Delhi Network of Positive People opposition, Lenacapavir, (201917006277)

Countries: India Date: 2021
The Delhi Network of Positive People opposition, Glecaprevir / Pibrentasvir, (201817002543)

Countries: India Date: 2021
Delhi Network of Positive People (DNP+) opposition, Bedaquiline, Pretomanid and Linezolid, (201817014361)

Countries: India Date: 2020
Delhi Network of Positive People (DNP+) opposition, Glecaprevir / Pibrentasvir , (201817002543)

Countries: India Date: 2021
Delhi Network of Positive People (DNP+) opposition, Lumacaftor, (3158/KOLNP/2012)

Countries: India Date: 2021
Delhi Network of Positive People (DNP+) and Ganesh Acharya opposition, Bedaquiline, (201727030045)

Countries: India Date: 2020
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002757)

Countries: India Date: 2019
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002758)

Countries: India Date: 2019
Delhi Network of Positive People (DNP+) opposition, efavirenz (EFV) , (IN/PCT/2000/00553/MUM (granted as: 195367))

Countries: India Date: 2007